Authors: Tran, GQ Bux, DA Haug, NA Stitzer, ML Svikis, DS

Citation: Gq. Tran et al., MMPI-2 typology of pregnant drug-dependent women in treatment, PSYC ASSESS, 13(3), 2001, pp. 336-346

Authors: Kissin, WB Svikis, DS Morgan, GD Haug, NA

Citation: Wb. Kissin et al., Characterizing pregnant drug-dependent women in treatment and their children, J SUBST ABU, 21(1), 2001, pp. 27-34

Authors: Johnson, RE Jones, HE Jasinski, DR Svikis, DS Haug, NA Jansson, LM Kissin, WB Alpan, G Lantz, ME Cone, EJ Wilkins, DG Golden, AS Huggins, GR Lester, BM

Citation: Re. Johnson et al., Buprenorphine treatment of pregnant opioid-dependent women: maternal and neonatal outcomes, DRUG AL DEP, 63(1), 2001, pp. 97-103

Authors: Moylan, PL Jones, HE Haug, NA Kissin, WB Svikis, DS

Citation: Pl. Moylan et al., Clinical and psychosocial characteristics of substance-dependent pregnant women with and without PTSD, ADDICT BEHA, 26(3), 2001, pp. 469-474

Authors: Miles, DR Svikis, DS Kulstad, JL Haug, NA

Citation: Dr. Miles et al., Psychopathology in pregnant drug-dependent women with and without comorbidalcohol dependence, ALC CLIN EX, 25(7), 2001, pp. 1012-1017

Authors: Jones, HE Haug, NA Stitzer, ML Svikis, DS

Citation: He. Jones et al., Improving treatment outcomes for pregnant drug-dependent women using low-magnitude voucher incentives, ADDICT BEHA, 25(2), 2000, pp. 263-267